Literature DB >> 26236577

Challenges in Studying Modifiable Risk Factors for Birth Defects.

Sarah C Tinker1, Suzanne Gilboa1, Jennita Reefhuis1, Mary M Jenkins1, Marcy Schaeffer1, Cynthia A Moore1.   

Abstract

Conducting research to identify modifiable risk factors for birth defects is difficult for a variety of reasons. While some challenges are familiar to researchers across many disciplines, the confluence of issues affecting birth defects research may not be well understood by those outside of the field. This article describes several methodological challenges to the study of birth defects and ways these challenges might be addressed: (1) ascertainment, definition and classification of birth defects; (2) exposure assessment on modifiable risk factors; (3) analytical challenges related to small numbers and multiple statistical tests; (4) the role of genetics, including the collection of specimens and analysis of genetic data; and (5) challenges in translating research and demonstrating public health impact. Understanding these issues is important for researchers planning studies, reviewers evaluating the scientific merit of results from these studies, and consumers of the research, including fellow researchers, policy makers, health care providers, and families.

Entities:  

Keywords:  birth defects; case classification; case definition; public health impact; research methods

Year:  2015        PMID: 26236577      PMCID: PMC4516719          DOI: 10.1007/s40471-014-0028-y

Source DB:  PubMed          Journal:  Curr Epidemiol Rep


  87 in total

Review 1.  Gene-environment interactions in human diseases.

Authors:  David J Hunter
Journal:  Nat Rev Genet       Date:  2005-04       Impact factor: 53.242

2.  Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa).

Authors:  Per Magnus; Lorentz M Irgens; Kjell Haug; Wenche Nystad; Rolv Skjaerven; Camilla Stoltenberg
Journal:  Int J Epidemiol       Date:  2006-08-22       Impact factor: 7.196

Review 3.  The National Birth Defects Prevention Study: how to communicate data.

Authors:  Anthony R Scialli
Journal:  Semin Fetal Neonatal Med       Date:  2013-10-04       Impact factor: 3.926

4.  Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP).

Authors:  Robert L Davis
Journal:  J Popul Ther Clin Pharmacol       Date:  2010-10-26

5.  Racial and ethnic disparity in participation in DNA collection at the Atlanta site of the National Birth Defects Prevention Study.

Authors:  Krista S Crider; Jennita Reefhuis; Alison Woomert; Margaret A Honein
Journal:  Am J Epidemiol       Date:  2006-07-28       Impact factor: 4.897

6.  The use of dysmorphology in birth defects epidemiology.

Authors:  J M Friedman
Journal:  Teratology       Date:  1992-02

7.  Maternal attitudes toward DNA collection for gene-environment studies: a qualitative research study.

Authors:  Mary M Jenkins; Erika Reed-Gross; Sonja A Rasmussen; Wanda D Barfield; Christine E Prue; Margaret L Gallagher; Margaret A Honein
Journal:  Am J Med Genet A       Date:  2009-11       Impact factor: 2.802

8.  Smoking during pregnancy--United States, 1990-2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-10-08       Impact factor: 17.586

9.  Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis?

Authors:  Martha M Werler; Allen A Mitchell; Cynthia A Moore; Margaret A Honein
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

10.  Factors affecting maternal participation in the genetic component of the National Birth Defects Prevention Study-United States, 1997-2007.

Authors:  Jill Glidewell; Jennita Reefhuis; Sonja A Rasmussen; Alison Woomert; Charlotte Hobbs; Paul A Romitti; Krista S Crider
Journal:  Genet Med       Date:  2013-09-26       Impact factor: 8.822

View more
  15 in total

1.  Editorial perspectives from the founding CDC leadership of the National Birth Defects Prevention study.

Authors:  Cynthia A Moore; Paula W Yoon; Larry D Edmonds; J David Erickson
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-06-10

2.  Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011.

Authors:  Sarah C Tinker; Jennita Reefhuis; Rebecca H Bitsko; Suzanne M Gilboa; Allen A Mitchell; Emmy L Tran; Martha M Werler; Cheryl S Broussard
Journal:  Birth Defects Res       Date:  2019-03-19       Impact factor: 2.344

3.  Power in numbers.

Authors:  Evelyne Vinet; Eliza F Chakravarty; Megan E B Clowse
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

4.  Evaluating the proportion of isolated cases among a spectrum of birth defects in a population-based registry.

Authors:  Peter H Langlois; Lisa Marengo; Philip J Lupo; Margaret Drummond-Borg; A J Agopian; Wendy N Nembhard; Mark A Canfield
Journal:  Birth Defects Res       Date:  2022-02-26       Impact factor: 2.661

5.  Maternal exposure to outdoor air pollution and congenital limb deficiencies in the National Birth Defects Prevention Study.

Authors:  Giehae Choi; Jeanette A Stingone; Tania A Desrosiers; Andrew F Olshan; Wendy N Nembhard; Gary M Shaw; Shannon Pruitt; Paul A Romitti; Mahsa M Yazdy; Marilyn L Browne; Peter H Langlois; Lorenzo Botto; Thomas J Luben
Journal:  Environ Res       Date:  2019-09-10       Impact factor: 6.498

Review 6.  The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review.

Authors:  Per Damkier; Poul Videbech
Journal:  CNS Drugs       Date:  2018-04       Impact factor: 5.749

7.  Quantification of selection bias in studies of risk factors for birth defects among livebirths.

Authors:  Dominique Heinke; Janet W Rich-Edwards; Paige L Williams; Sonia Hernandez-Diaz; Marlene Anderka; Sarah C Fisher; Tania A Desrosiers; Gary M Shaw; Paul A Romitti; Mark A Canfield; Mahsa M Yazdy
Journal:  Paediatr Perinat Epidemiol       Date:  2020-04-06       Impact factor: 3.103

Review 8.  Zika Virus-Associated Birth Defects, Costa Rica, 2016-2018.

Authors:  Adriana Benavides-Lara; María de la Paz Barboza-Arguello; Mauricio González-Elizondo; Marcela Hernández-deMezerville; Helena Brenes-Chacón; Melissa Ramírez-Rojas; Catalina Ramírez-Hernández; Nereida Arjona-Ortegón; Shana Godfred-Cato; Diana Valencia; Cynthia A Moore; Alejandra Soriano-Fallas
Journal:  Emerg Infect Dis       Date:  2021-02       Impact factor: 6.883

9.  Comparative analysis of perinatal outcomes and birth defects amongst adolescent and older Ugandan mothers: evidence from a hospital-based surveillance database.

Authors:  Robert Serunjogi; Linda Barlow-Mosha; Daniel Mumpe-Mwanja; Dhelia Williamson; Diana Valencia; Sarah C Tinker; Michelle R Adler; Joyce Namale-Matovu; Dennis Kalibbala; Jolly Nankunda; Evelyn Nabunya; Doreen Birabwa-Male; Josaphat Byamugisha; Philippa Musoke
Journal:  Reprod Health       Date:  2021-03-04       Impact factor: 3.223

10.  Disinfection By-Product Exposures and the Risk of Musculoskeletal Birth Defects.

Authors:  John A Kaufman; J Michael Wright; Amanda Evans; Zorimar Rivera-Núñez; Amy Meyer; Michael G Narotsky
Journal:  Environ Epidemiol       Date:  2020-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.